🇺🇸 VONVENDI in United States
145 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 145
Most-reported reactions
- No Adverse Event — 42 reports (28.97%)
- Drug Ineffective — 16 reports (11.03%)
- Haemorrhage — 15 reports (10.34%)
- Off Label Use — 14 reports (9.66%)
- Haemarthrosis — 11 reports (7.59%)
- Product Reconstitution Quality Issue — 11 reports (7.59%)
- Epistaxis — 10 reports (6.9%)
- Gastrointestinal Haemorrhage — 10 reports (6.9%)
- Product Dose Omission Issue — 9 reports (6.21%)
- Device Malfunction — 7 reports (4.83%)
Other Hematology approved in United States
Frequently asked questions
Is VONVENDI approved in United States?
VONVENDI does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for VONVENDI in United States?
Takeda is the originator. The local marketing authorisation holder may differ — check the official source linked above.